Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity
A molecular model was built for human lecithin:cholesterol acyltransferase (LCAT) based upon the structural homology between this enzyme and lipases (Peelman et al. 1998. Prot. Sci. 7: 585–597). We proposed that LCAT belongs to the α/β hydrolase fold family, and that the central domain of LCAT consi...
Main Authors: | F. Peelman, J-L. Verschelde, B. Vanloo, C. Ampe, C. Labeur, J. Tavernier, J. Vandekerckhove, M. Rosseneu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-01-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520333393 |
Similar Items
-
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01) -
Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
by: John K. Bielicki, et al.
Published: (1999-05-01) -
Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase
by: Margaret E. Brousseau, et al.
Published: (1998-08-01) -
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
by: Andrea Baragetti, et al.
Published: (2020-07-01) -
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol
by: Kelly A Manthei, et al.
Published: (2018-11-01)